Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab

BACKGROUND: Despite the good outcomes achieved with intravitreal angiogenic therapy, a subset of neovascular age-related macular degeneration (AMD) patients experience resistance to therapy after repeated injections. Switching drugs could offer benefit to this group of patients. PURPOSE: To determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Mohamed A., Abdelfattah, Nizar S., Salamzadeh, Jamshid, Abdelaziz, Sahar T. A., Sabry, Ahmed M., Mourad, Khaled M., Shehab, Azza A., Kuppermann, Baruch D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017745/
https://www.ncbi.nlm.nih.gov/pubmed/33795022
http://dx.doi.org/10.1186/s40942-021-00299-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017745/
https://www.ncbi.nlm.nih.gov/pubmed/33795022
http://dx.doi.org/10.1186/s40942-021-00299-4

Ejemplares similares